CRA International vs FTI Consulting
CRAI and FCN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRAI and FCN compare
FTI Consulting is the larger company, worth 4.2 times as much as CRA International ($5.6B against $1.4B).
On earnings, FTI Consulting is cheaper: it trades at 25.8× trailing earnings, against 28.6× for CRA International.
CRA International grew revenue faster over the last twelve months (11.5% versus 7.8% for FTI Consulting).
CRA International keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 5.9% at FTI Consulting.
CRA International pays a dividend yielding 1.1%; FTI Consulting does not pay one.
CRA International scores higher on the StockData Score (12 against 10 for FTI Consulting), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRAI | FCN |
|---|---|---|
| Size and price | ||
| Market cap | $1.4B | $5.6B |
| Share price | $215.44 | $206.66 |
| Change, 1 year | 24.7% | 28.1% |
| Change, 5 years | 122% | 41.0% |
| Beta (5Y) | 0.58 | 0.10 |
| Employees | 597 | 8,118 |
| StockData Score | ||
| Total score | 12 (better) | 10 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 5 (better) | 4 |
| Health score | 2 | 4 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 28.6× | 25.8× (better) |
| P/S | 1.7× | 1.4× (better) |
| P/B | 7.4× | 4.3× (better) |
| EV/EBITDA | 14.3× (better) | 15.9× |
| P/FCF | – | 15.9× |
| PEG | 2.54 (better) | 3.31 |
| FCF yield | −2.1% | 6.3% (better) |
| Fair value | $160.10 | $169.37 |
| Margin of safety | −34.6% | −22.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.5% (better) | 7.8% |
| Revenue growth, 5Y average | 8.1% | 9.0% (better) |
| Net income growth (TTM) | −12.8% | −12.3% (better) |
| EPS growth (TTM) | −9.1% | 2.0% (better) |
| EPS growth, 5Y average | 21.5% (better) | 7.8% |
| Profitability | ||
| Gross margin | 29.0% | 32.2% (better) |
| Operating margin | 10.0% (better) | 8.8% |
| Net margin | 6.2% (better) | 5.9% |
| FCF margin | −3.5% | 8.9% (better) |
| Return on equity | 26.0% (better) | 15.2% |
| Return on invested capital | 32.0% (better) | 12.4% |
| Financial health | ||
| Debt / equity | – | 0.64 |
| Net debt / EBITDA | – | 1.90 |
| Interest coverage | 11.2× (better) | 9.0× |
| Current ratio | 0.82 | 1.72 (better) |
| Altman Z-score | 3.45 | 3.88 (better) |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | – |
| Payout ratio | 29.2% | – |
| Years of dividend growth | 9 | – |
| Dividend growth, 5Y average | 16.5% | – |
| Buyback yield | 3.9% | 12.3% (better) |
| Shareholder yield | 5.0% | 12.3% (better) |
| Ownership | ||
| Held by institutions | 94.8% | 112% |
| Held by insiders | 3.7% | 2.5% |
| Insider net buying, 12 months | −$6.2M | −$342K (better) |
| Short interest, % of float | 5.0% | 9.9% |
Go deeper
- CRAI stock overview
- CRAI income statement
- CRAI valuation and score
- FCN stock overview
- FCN income statement
- FCN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.